课题基金 / 基金详情

The Role of HMGB1 in autophagy deficiency-induced liver pathology

The Role of HMGB1 in autophagy deficiency-induced liver pathology
HMGB1 在自噬缺陷引起的肝脏病理中的作用
批准号:
10137441
负责人:
XIAO-MING YIN
金额:
$35.35万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-26 至 2022-05-31

项目摘要

项目成果

XIAO-MING YIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Macroautophagy, hereafter referred to as autophagy, is an evolutionarily conserved intracellular degradation mechanism involved in diverse biological activities and in the pathogenesis of many diseases. The homeostatic importance of autophagy for the liver is indicated in the fact that autophagy deficiency causes multiple liver pathologies, including hepatomegaly, injury, inflammation, ductular reaction, fibrosis and tumorigenesis. What are being triggered by autophagy deficiency to lead to these changes are largely unknown but understanding the involved mechanisms will provide the insight not only on how autophagy maintains hepatic homeostasis, but also on how similar processes occur in other chronic diseases, such as those caused by alcohol, hyper-nutrients, and hepatic viruses. Toward that end, we have found that HMGB1 is actively released from autophagy-deficient hepatocytes, which is different from the more commonly seen case of passive release from dead cells during injury, but is similar to the active release by macrophages during inflammation. Regulatory mechanisms including Nrf2 and Caspase1 affect HMGB1 release independently from liver injury. HMGB1 acts in an extracellular mode and requires its receptor, RAGE, to regulate the ductular reaction, i.e., the expansion of ductular cells (DRs), also known as hepatic progenitor cells (HPCs) or oval cells, and to promote the development of hepatic tumors. These results indicate that hepatic HMGB1 plays an important and unique role in the liver pathogenesis caused by autophagy deficiency. The proposal have three aims. In Aim 1 we will investigate the mechanism of HMGB1 release from hepatocytes, addressing the hypothesis that inflammasomes are involved in the process. In Aim 2 we will examine the mechanism of ductular reaction promoted by HMGB1. In Aim 3 we will dissect the mechanisms of HMGB1 in tumor progression by examining the hypothesis that HMGB1 may alter the hepatic microenvironment. The successful completion of this work will reveal the novel roles of hepatocyte-derived HMGB1 in hepatic homeostasis and the results may be generally applicable to similar pathogenic processes in other types of chronic liver diseases, thus advancing the research in this field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of HMGB1 in autophagy deficiency-induced liver pathology
  • 批准号:
    10188516
  • 项目类别:
  • 资助金额:
    $40.04万
  • 财政年份:
    2018
  • 负责人:
    XIAO-MING YIN
  • 依托单位:
The Role of HMGB1 in autophagy deficiency-induced liver pathology
Mechanism and role of selective autophagy in ethanol-induced liver injury
Mechanism and role of selective autophagy in ethanol-induced liver injury
国内基金
海外基金
PGK1 通过稳定HMGB1 介导多发性骨髓瘤免疫逃逸的机制研究
  • 批准号:
    ZCLMS26H0802
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    陈颖
  • 依托单位:
Hippo/YAP通路通过HMGB1调控自噬在中耳胆脂瘤角质形成细胞过度增殖中的机制研究
  • 批准号:
    2026JJ50276
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘伟
  • 依托单位:
基于scRNA-seq和多组学策略探讨加味脑泰方调控HMGB1/Nrf2/HO-1信号改善VD神经元铁死亡的机制
  • 批准号:
    2026JJ81027
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    易亚乔
  • 依托单位:
基于HMGB1因子研究电针通过TLR4/NF-κB通路影响小胶质细胞活化治疗慢性偏头痛中枢敏化的作用机制